European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables
1999 · British Journal of Cancer · 17 citations
https://doi.org/10.1038/sj.bjc.6690435
M
MW Beckmann
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
586
Papers
2.0K
Citations
22
h-index
51
i10-index
MW Beckmann is an academic researcher from Friedrich-Alexander-Universität Erlangen-Nürnberg. The author has contributed to research in topics: Breast Cancer Treatment Studies & Estrogen and related hormone effects & HER2/EGFR in Cancer Research. The author has an h-index of 22, co-authored 499 publications.
Papers by this author
worksErratum to “Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients—Design and baseline data ‘LIBERATE’ trial” [The Breast 16S2 (2007) S182–S189]
2008 · The Breast · 7 citations
https://doi.org/10.1016/j.breast.2008.01.002
Detection of the HER-2/neu proto-oncogene protein p185erbB2 by a novel monoclonal antibody (MAB-145ww) in breast cancer membranes from oestrogen and progesterone receptor assays
1992 · European Journal of Cancer · 6 citations
https://doi.org/10.1016/s0959-8049(05)80046-2
Prognosis prediction with the IHC3 score in patients with node-negative, hormone receptor-positive, HER2-negative early breast cancer
2024 · ESMO Open · 1 citations
https://doi.org/10.1016/j.esmoop.2024.103963
CD95 ligand expression mediates immune escape in breast cancer
2001 · Breast Cancer Research · 0 citations
https://doi.org/10.1186/bcr406
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat